Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/NOVARTIS-AG-9364983/news/Novartis-erhalt-positive-CHMP-Stellungnahme-fur-Kymriah-bei-zwei-Blutkrebsarten-26852060/?utm_source=whatsapp&utm_medium=social&utm_campaign=share